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Volume 59, Number 6S Abstracts 59Sand 1.47 for segments <50% stenosis (P < .001). Sensi-
tivity was 0.60, speciﬁcity was 0.86, positive predictive
value (PPV) was 0.72 and negative predictive value
(NPV) was 0.78 for PSV >500 cm/s. Sensitivity was
0.52, speciﬁcity was 0.91, PPV was 0.77, and NPV was
0.75 for VR >3.0. Receiver operating characteristic curve
discrimination was 0.85 for PSV and 0.84 for VR (Fig),
suggesting good ability to classify lesions as hemodynami-
cally signiﬁcant.
Conclusions: Duplex PSV and the VR provide good
sensitivity and speciﬁcity to distinguish hemodynamically
signiﬁcant lesions in arteriovenous ﬁstulas and grafts. PSV
>500 cm/s and VR >3.0 can be used as criteria to inter-
rogate AV access for stenoses by angiography with high
speciﬁcity for hemodynamically signiﬁcant lesions.
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Objectives: Several patients are unsuitable for autoge-
nous dialysis access and are consigned to perpetual
prosthetic graft placement. We hypothesized that dialysis
procedures result in dilation of residual upper extremity
(UE) veins not in direct communication with the ﬁstula.
Dilation of these veins would have clinical relevance, since
some may later became suitable for autogenous accesses.
Our aim was to measure the frequency, magnitude, and
clinical relevance of this process.
Methods: Patients undergoing their ﬁrst access had
duplex ultrasound diameter measurements of cephalic
and basilic veins at eight sites (wrist, distal/middle/
proximal forearm, cubital fossa, and distal/middle/prox-
imal arm). An optimal vein segment was $2.5-mm diam-
eter over a $10-cm length. A ﬁstula was constructed
using the best available vein segment, comprising forearm
nontransposed (n ¼ 9), forearm transposed (n ¼ 8), and
arm transposed (n ¼ 18). Diameters of the ipsilateral basilic
and cephalic vein segments that were not used for the ﬁs-
tula were remeasured on follow-up.
Results: Of 108 patients who were screened, 71 met
inclusion criteria, and 34 completed the study with a
follow-up period of 4 to 12 months. The mean diameter
of vein segments not used for ﬁstula creation increased by
52%, from 2.3 6 0.5 to 3.5 6 0.5 mm (P ¼ .01). Two
ﬁstulae thrombosed, but new ﬁstulae could be constructed
in alternate vein segments that had originally been subopti-
mal (<2 mm) in diameter. At least one vein segment dilated
to $2.5 mm in 54% of our patients and at least one vein
segment dilated to $3 mm in 37% of our patients.
Conclusions: Dialysis access using one upper extrem-
ity vein segment results in progressive dilation of the resid-
ual venous segments. In about one-third of patients
undergoing surgery for the ﬁrst time, vein segmentsinitially deemed suboptimal had dilated to $3 mm. This
is especially relevant in patients receiving prosthetic grafts
for suboptimal venous anatomy. Our results may impact
the Disease Outcomes Quality Initiative guidelines for se-
lection of dialysis access procedures.
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Objectives: End-stage renal disease and the need for
dialysis is a growing problem. More than 60% of arteriove-
nous ﬁstulas are unsuitable for dialysis 5 months after sur-
gery. This early failure rate is due to severe narrowing of
the juxta-anastomotic vein segment in 41% to 64% of cases.
Trauma to the juxta-anastomotic vein segment during
mobilization and turbulent hemodynamic forces are theo-
rized to contribute to the scarring process observed. To pre-
vent juxta-anastomotic stenosis and promote improved
maturation rates, we initiated a pilot study placing a covered
endograft into the juxta-anastomotic vein segment at the
time of AV ﬁstula creationdthe JuxtaBahn procedure.
Methods: Patients referred for long-term dialysis ac-
cess placement underwent radiocephalic or brachiocephalic
ﬁstula creation. During the standard procedure, a 2 cm or 5
cm Viabahn endograft (6-mm diameter) was placed into
the juxta-anastomotic segment of the outﬂow cephalic
vein. The anchoring suture in the heel of the anastomosis
went through cephalic vein, endograft, and artery. The
remaining hood of the anastomosis was native vein, and
the anastomosis was completed in a standard end-to-side
fashion. Surveillance ultrasound studies were obtained at
1, 3, 6, and 12 months.
Results: The JuxtaBahn AV ﬁstula technique was suc-
cessfully completed in 11 patients (seven radiocephalic and
four brachiocephalic ﬁstulas). Follow-up ranged from 3
to 12 months. No early juxta-anastomotic stenoses were
identiﬁed Eighty-two percent of ﬁstulas matured. There
were no AV ﬁstula infections. One (9%) AV ﬁstula
occluded at 2 weeks (2 mm cephalic vein). One AV ﬁstula
(1/11) required ligation.
Conclusions: The JuxtaBahn procedure is a viable
procedure with no major adverse outcomes. No early
juxta-anastomotic stenoses were identiﬁed in our pilot
study. There is a trend toward higher maturation and lower
occlusion rates. A larger prospective, randomized series is
required to better evaluate the JuxtaBahn procedure.
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